SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Alpha Cognition Inc.
Date: Aug. 28, 2025 · CIK: 0001655923 · Accession: 0000000000-25-009243

Regulatory Compliance Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289792

Date
August 28, 2025
Author
Division of
Form
UPLOAD
Company
Alpha Cognition Inc.

Letter

Re: Alpha Cognition Inc. Registration Statement on Form S-3 Filed August 22, 2025 File No. 333-289792 Dear Michael McFadden:

August 28, 2025

Michael McFadden Chief Executive Officer Alpha Cognition Inc. 1452 Hughes Rd., Ste 200 Grapevine, Texas, 76051

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tim Buchmiller at 202-551-3635 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jason K. Brenkert, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 August 28, 2025

Michael McFadden
Chief Executive Officer
Alpha Cognition Inc.
1452 Hughes Rd., Ste 200
Grapevine, Texas, 76051

 Re: Alpha Cognition Inc.
 Registration Statement on Form S-3
 Filed August 22, 2025
 File No. 333-289792
Dear Michael McFadden:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Tim Buchmiller at 202-551-3635 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Jason K. Brenkert, Esq.
</TEXT>
</DOCUMENT>